Corpus Intelligence IC Memo — SUMMIT MEDICAL CENTER 2026-04-26 05:27 UTC
IC Memo — SUMMIT MEDICAL CENTER
Investment Committee Memorandum | TN | 188 beds | Grade C | EBITDA uplift $21.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SUMMIT MEDICAL CENTER

CCN 440150 | DAVIDSON, TN | 188 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SUMMIT MEDICAL CENTER is a 188-bed suburban community hospital in DAVIDSON, TN with $298.0M in net patient revenue and a 40.6% operating margin. The hospital serves a payer mix of 23.6% Medicare, 7.9% Medicaid, and 68.5% commercial.

Thesis: Turnaround. Our ML models identify $21.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 40.6% to 48.0% (+736bps).

Net Revenue HCRIS$298.0M
Current EBITDA COMPUTED$121.0M
Operating Margin COMPUTED40.6%
Occupancy HCRIS81.8%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS13.6%
Distress Probability ML39.6%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
38
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 40.6% places it above the state median. Among 38 size-comparable peers (94-376 beds), the median margin is 1.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (94-376), prioritizing same-state peers. 38 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SUMMIT MEDICAL CENTER (Target)TN188$298.0M40.6%
SAINT THOMAS RUTHERFORD HOSPITTN354$447.4M1.3%
REGIONAL ONE HEALTHTN291$407.9M-50.0%
PARKWEST MEDICAL CENTERTN361$396.4M-5.5%
COOKEVILLE REGIONAL MEDICAL CETN212$372.5M2.1%
SKYLINE MEDICAL CENTERTN350$360.4M15.1%
FORT SANDERS REGIONAL MEDICAL TN304$346.2M-9.4%
HOLSTON VALLEY HOSP & MED CTRTN286$344.6M-7.4%
MAURY REGIONAL HOSPITALTN244$334.0M-9.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $21.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.3M+210bp18mo
Cost to Collect4.5%2.5%$6.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.6M+122bp9mo
Clean Claim Rate88.0%96.0%$191K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.3M
Cost to Collect
$6.0M
Denial Rate Reduction
$5.9M
A/R Days Reduction
$3.6M
Clean Claim Rate
$191K
Total EBITDA Uplift$21.9M
Current EBITDA$121.0M
+ RCM Uplift+$21.9M
Pro Forma EBITDA$143.0M
Current Margin40.6%
Pro Forma Margin48.0%
WC Released (1x)$11.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$186.2M$1.02B5.47x40.5%
Base (11x exit)10.0x11.0x$186.2M$1.18B6.34x44.7%
Bull Case9.0x11.0x$167.6M$1.31B7.83x50.9%
Bull (12x exit)9.0x12.0x$167.6M$1.48B8.84x54.6%
Bear Case11.0x10.0x$204.8M$847.6M4.14x32.9%
Bear (11x exit)11.0x11.0x$204.8M$998.9M4.88x37.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 38 hospitals with 94-376 beds
  • Same-state prioritization (n=39)
  • Comp margins: P25=-7.4% / P50=1.5% / P75=12.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.